Lederer & Associates Investment Counsel Merck & Co., Inc. Transaction History
Lederer & Associates Investment Counsel
- $143 Million
- Q4 2024
A detailed history of Lederer & Associates Investment Counsel transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lederer & Associates Investment Counsel holds 8,968 shares of MRK stock, worth $813,756. This represents 0.62% of its overall portfolio holdings.
Number of Shares
8,968
Previous 7,849
14.26%
Holding current value
$813,756
Previous $891,000
0.11%
% of portfolio
0.62%
Previous 0.63%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.87BCall Options Held
15.5MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA250MShares$22.7 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$10.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$6.88 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.37 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $230B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...